Abstract
There is growing evidence implicating dysfunctional glutamatergic neurotransmission and abnormal interactions between the glutamate and dopamine (DA) systems in the pathophysiology of various neuropsychiatric disorders including schizophrenia. The present study evaluated knockout (KO) mice lacking the L-α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) GluR1 receptor subunit for a range of behaviors considered relevant to certain symptoms of schizophrenia. KO showed locomotor hyperactivity during exposure to open field and in response to a novel object, but normal activity in a familiar home cage. Open field locomotor hyperactivity in KO was effectively normalized to WT levels by treatment with the DA antagonist and neuroleptic haloperidol, while locomotor stimulant effects of the NMDA receptor antagonist MK-801 were absent in KO. Social behaviors during a dyadic conspecific encounter were disorganized in KO. KO showed deficits in prepulse inhibition of the acoustic startle response. In vivo chronoamperometric measurement of extracellular DA clearance in striatum demonstrated retarded clearance in KO. These data demonstrate behavioral abnormalities potentially pertinent to schizophrenia in GluR1 KO, together with evidence of dysregulated DA function. Present findings provide novel insight into the potential role of GluR1, AMPA receptors and glutamate × DA interactions in the pathophysiology of schizophrenia and other neuropsychiatric conditions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harrison PJ, Weinberger DR . Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40–68; image 5.
Coyle JT . Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26: 365–384.
Krystal JH, Anand A, Moghaddam B . Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry 2002; 59: 663–664.
Olney JW, Newcomer JW, Farber NB . NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999; 33: 523–533.
Lewis DA, Gonzalez-Burgos G . Pathophysiologically based treatment interventions in schizophrenia. Nat Med 2006; 12: 1016–1022.
Malenka RC . The long-term potential of LTP. Nat Rev Neurosci 2003; 4: 923–926.
Malinow R, Malenka RC . AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002; 25: 103–126.
Eastwood SL, Kerwin RW, Harrison PJ . Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia. Biol Psychiatry 1997; 41: 636–643.
Sokolov BP . Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of ‘neuroleptic-free’ schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J Neurochem 1998; 71: 2454–2464.
Meador-Woodruff JH, Hogg Jr AJ, Smith RE . Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder. Brain Res Bull 2001; 55: 631–640.
Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K et al. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 2002; 83: 797–806.
O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES . AMPA receptor potentiators for the treatment of CNS disorders. Curr Drug Targets CNS Neurol Disord 2004; 3: 181–194.
Marenco S, Weinberger DR . Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders. CNS Drugs 2006; 20: 173–185.
Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C et al. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 2004; 9: 213–218.
Gogos JA, Gerber DJ . Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 2006; 27: 226–233.
Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT . Neurobiology of schizophrenia. Neuron 2006; 52: 139–153.
Magri C, Gardella R, Barlati SD, Podavini D, Iatropoulos P, Bonomi S et al. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 287–293.
Cryan JF, Holmes A . The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4: 775–790.
Seeburg PH, Single F, Kuner T, Higuchi M, Sprengel R . Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse. Brain Res 2001; 907: 233–243.
Holmes A, Lachowicz JE, Sibley DR . Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology 2004; 47: 1117–1134.
Arguello PA, Gogos JA . Modeling madness in mice: one piece at a time. Neuron 2006; 52: 179–196.
Chen J, Lipska BK, Weinberger DR . Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models. Biol Psychiatry 2006; 59: 1180–1188.
Powell CM, Miyakawa T . Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 2006; 59: 1198–1207.
Morishima Y, Miyakawa T, Furuyashiki T, Tanaka Y, Mizuma H, Nakanishi S . Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc Natl Acad Sci USA 2005; 102: 4170–4175.
Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK et al. Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 2005; 4: 273–288.
Mohn AR, Gainetdinov RR, Caron MG, Koller BH . Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98: 427–436.
Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS et al. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci USA 2004; 101: 8485–8490.
Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 2003; 100: 8987–8992.
Ballard TM, Pauly-Evers M, Higgins GA, Ouagazzal AM, Mutel V, Borroni E et al. Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity. J Neurosci 2002; 22: 6713–6723.
Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A et al. Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999; 284: 1805–1811.
Schmitt WB, Deacon RM, Seeburg PH, Rawlins JN, Bannerman DM . A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice. J Neurosci 2003; 23: 3953–3959.
Reisel D, Bannerman DM, Schmitt WB, Deacon RM, Flint J, Borchardt T et al. Spatial memory dissociations in mice lacking GluR1. Nat Neurosci 2002; 5: 868–873.
Reisel D, Bannerman DM, Deacon RM, Sprengel R, Seeburg PH, Rawlins JN . GluR-A-dependent synaptic plasticity is required for the temporal encoding of nonspatial information. Behav Neurosci 2005; 119: 1298–1306.
Vekovischeva OY, Aitta-Aho T, Echenko O, Kankaanpaa A, Seppala T, Honkanen A et al. Reduced aggression in AMPA-type glutamate receptor GluR-A subunit-deficient mice. Genes Brain Behav 2004; 3: 253–265.
Vekovischeva OY, Zamanillo D, Echenko O, Seppala T, Uusi-Oukari M, Honkanen A et al. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J Neurosci 2001; 21: 4451–4459.
Dong Y, Saal D, Thomas M, Faust R, Bonci A, Robinson T et al. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(−/−) mice. Proc Natl Acad Sci USA 2004; 101: 14282–14287.
Stephens DN, Mead AN . What role do GluR1 subunits play in drug abuse? Trends Neurosci 2003; 26: 181–182; author reply 182–183.
Carlsson M, Carlsson A . Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson's disease. Trends Neurosci 1990; 13: 272–276.
Boyce-Rustay JM, Holmes A . Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006; 31: 2405–2414.
Gainetdinov RR, Mohn AR, Bohn LM, Caron MG . Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 2001; 98: 11047–11054.
Millstein RA, Ralph RJ, Yang RJ, Holmes A . Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav 2006; 5: 346–354.
Daws LC, Montanez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM et al. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci 2006; 26: 6431–6438.
Daws LC, Montanez S, Owens WA, Gould GG, Frazer A, Toney GM et al. Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. J Neurosci Methods 2005; 143: 49–62.
Paxinos KBJ, Franklin G . The Mouse Brain in Stereotaxic Coordinates, 2nd edn. Academic Press: London, 2001.
Zahniser NR, Larson GA, Gerhardt GA . In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther 1999; 289: 266–277.
Hebert MA, Larson GA, Zahniser NR, Gerhardt GA . Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat. J Pharmacol Exp Ther 1999; 288: 1334–1339.
Bannerman DM, Deacon RM, Seeburg PH, Rawlins JN . GluR-A-Deficient mice display normal acquisition of a hippocampus-dependent spatial reference memory task but are impaired during spatial reversal. Behav Neurosci 2003; 117: 866–870.
Moghaddam B . Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 2002; 51: 775–787.
Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR . Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001; 156: 117–154.
Holmes A, Wrenn CC, Harris AP, Thayer KE, Crawley JN . Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice. Genes Brain Behav 2002; 1: 55–69.
Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH . The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 1998; 31 (Suppl 2): 104–109.
Chandler LJ, Sutton G, Dorairaj NR, Norwood D . N-methyl D-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J Biol Chem 2001; 276: 2627–2636.
Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR et al. Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci 2001; 115: 1129–1144.
Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 2001; 98: 1982–1987.
Amara SG, Kuhar MJ . Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993; 16: 73–93.
Acknowledgements
Research supported by the National Institute on Alcohol Abuse and Alcoholism Intramural Research Program, a R01-MH64489 Grant to LCD, and NARSAD grants to LCD and AH.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Supplementary information
Rights and permissions
About this article
Cite this article
Wiedholz, L., Owens, W., Horton, R. et al. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors. Mol Psychiatry 13, 631–640 (2008). https://doi.org/10.1038/sj.mp.4002056
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002056
Keywords
This article is cited by
-
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salience
Molecular Psychiatry (2023)
-
Mechanisms and Functions of Activity-Regulated Cytoskeleton-Associated Protein in Synaptic Plasticity
Molecular Neurobiology (2023)
-
Evolutionarily conserved gene expression patterns for affective disorders revealed using cross-species brain transcriptomic analyses in humans, rats and zebrafish
Scientific Reports (2022)
-
Distinct contributions of GluA1-containing AMPA receptors of different hippocampal subfields to salience processing, memory and impulse control
Translational Psychiatry (2022)
-
KHSRP loss increases neuronal growth and synaptic transmission and alters memory consolidation through RNA stabilization
Communications Biology (2022)